Gene · 285335
Papers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,657
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma. | Int J Med Sci | 2023 | 36619227 | PubTator, text mining | PubMed |
| Gliflozins: From Antidiabetic Drugs to Cornerstone in Heart Failure Therapy-A Boost to Their Utilization and Multidisciplinary Approach in the Management of Heart Failure. | J Clin Med | 2023 | 36615178 | PubTator, text mining | PubMed |
| Probing Single-Cell Fermentation Fluxes and Exchange Networks via pH-Sensing Hybrid Nanofibers. | ACS Nano | 2023 | 36573897 | PubTator, text mining | PubMed |
| Importance of lactate dehydrogenase (LDH) and monocarboxylate transporters (MCTs) in cancer cells. | Health Sci Rep | 2023 | 36570342 | PubTator, text mining | PubMed |
| EPO has multiple positive effects on astrocytes in an experimental model of ischemia. | Brain Res | 2023 | 36549360 | PubTator, text mining | PubMed |
| Insulin may promote SARS-CoV-2 cell entry and replication in diabetes patients. | Med Hypotheses | 2023 | 36540082 | PubTator, text mining | PubMed |
| Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition. | J Exp Med | 2023 | 36520461 | PubTator, text mining | PubMed |
| Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression. | Diabetes Res Clin Pract | 2023 | 36502891 | PubTator, text mining | PubMed |
| Distinct effects of intracellular vs. extracellular acidic pH on the cardiac metabolome during ischemia and reperfusion. | J Mol Cell Cardiol | 2023 | 36481511 | PubTator, text mining | PubMed |
| The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases. | Mol Cell Biochem | 2023 | 36378463 | PubTator, text mining | PubMed |
| Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy. | J Mol Cell Cardiol | 2023 | 36370475 | PubTator, text mining | PubMed |
| Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus. | J Endocrinol Invest | 2023 | 36318448 | PubTator, text mining | PubMed |
| Combining sodium MRI, proton MR spectroscopic imaging, and intracerebral EEG in epilepsy. | Hum Brain Mapp | 2023 | 36217746 | PubTator, text mining | PubMed |
| Proton pump inhibitors display anti-tumour potential in glioma. | Cell Prolif | 2023 | 35961680 | PubTator, text mining | PubMed |
| Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect. | Heart Fail Rev | 2023 | 35133551 | PubTator, text mining | PubMed |
| Empagliflozin Ameliorates Ouabain-Induced Na+ and Ca2+ Dysregulations in Ventricular Myocytes in an Na+-Dependent Manner. | Cardiovasc Drugs Ther | 2023 | 34982348 | PubTator, text mining | PubMed |
| Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases. | Rev Physiol Biochem Pharmacol | 2023 | 32737755 | PubTator, text mining | PubMed |
| The Remaining Conundrum of the Role of the Na+/H+ Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified? | Rev Cardiovasc Med | 2022 | 39076631 | PubTator, text mining | PubMed |
| Physiological and Molecular Function of the Sodium/Hydrogen Exchanger NHA2 (SLC9B2). | Chimia (Aarau) | 2022 | 38069797 | PubTator, text mining | PubMed |
| Voltage-Gated Sodium Channel NaV1.5 Controls NHE-1-Dependent Invasive Properties in Colon Cancer Cells. | Cancers (Basel) | 2022 | 36612049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/285335/papers?page=9